Evidence map›Paper›PMID 38188450›Full record

ReviewWorld journal of critical care medicine2023

New-onset atrial fibrillation among COVID-19 patients: A narrative review.

Fahimeh Talaei, Akshat Banga, Amanda Pursell, Ann Gage, Namratha Pallipamu, Amith Reddy Seri, Ramesh Adhikari, Rahul Kashyap, Salim Surani

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Atrial fibrillation and flutter in the Eastern Mediterranean: burden, disparities, and risk factor contributions from 1990 to 2021.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Fahimeh TalaeiDepartment of Critical Care Medicine, Mayo Clinic, Phoenix, AZ 85054, United States.
Akshat BangaDepartment of Internal Medicine, Sawai Man Singh Medical College, Jaipur 302004, India.
Amanda PursellInternal Medicine, Tristar Centennial Medical Center, TriStar Division, HCA Healthcare, Nashville, TN 37203, United States.
Ann GageCardiology, TriStar Centennial Medical Center, TriStar Division, HCA Healthcare, Nashville, TN 37203, United States.
Namratha PallipamuDepartment of Medicine, Siddharta Medical College, Vijayawada 520008, Andhra Pradesh, India.
Amith Reddy SeriDepartment of Internal Medicine, Mclaren Regional Medical Center, Flint, MI 48532, United States.
Ramesh AdhikariDepartment of Internal Medicine, Franciscan Health, Lafayette, IN 46237, United States.
Rahul KashyapDepartment of Anaesthesiology & Critical Care Medicine, Mayo Clinic, Rochester, MN 55902, United States.
Salim SuraniDepartment of Anaesthesiology & Critical Care Medicine, Mayo Clinic, Rochester, MN 55902, United States.
Mayo Clinic Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the last three years, research has focused on examining cardiac issues arising from coronavirus disease 2019 (COVID-19) infection, including the emergence of new-onset atrial fibrillation (NOAF). Still, no clinical study was conducted on the persistence of this arrhythmia after COVID-19 recovery. Our objective was to compose a narrative review that investigates COVID-19-associated NOAF, emphasizing the evolving pathophysiological mechanisms akin to those suggested for sustaining AF. Given the distinct strategies involved in the persistence of atrial AF and the crucial burden of persistent AF, we aim to underscore the importance of extended follow-up for COVID-19-associated NOAF. A comprehensive search was conducted for articles published between December 2019 and February 11, 2023, focusing on similarities in the pathophysiology of NOAF after COVID-19 and those persisting AF. Also, the latest data on incidence, morbidity-mortality, and management of NOAF in COVID-19 were investigated. Considerable overlaps between the mechanisms of emerging NOAF after COVID-19 infection and persistent AF were observed, mostly involving reactive oxygen pathways. With potential atrial remodeling associated with NOAF in COVID-19 patients, this group of patients might benefit from long-term follow-up and different management. Future cohort studies could help determine long-term outcomes of NOAF after COVID-19.

Indexed as

Atrial fibrillationCOVID-19New-onset atrial fibrillationSARS-CoV-2

Identifiers

PMID38188450
PMCPMC10768419
OpenAlexW4389411635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.